ANI Pharmaceuticals | ANIP - Current Assets


ANI Pharmaceuticals reported $753.12M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
ANI Pharmaceuticals USD 753.12M 54.72M Dec/2025
Assertio Holdings USD 263.57M 53.36M Sep/2025
Aurora Cannabis CAD 445.84M 22M Dec/2025
Canopy Growth CAD 524.67M 78.85M Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Emergent BioSolutions USD 679.5M 41.3M Dec/2023
Heron Therapeutics USD 238.07M 8.67M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Nektar Therapeutics USD 266.27M 15.09M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Omeros USD 69.65M 26.53M Jun/2025
Perrigo USD 2.8B 81.8M Dec/2025
Sun Pharmaceuticals INR 601.36B 75.42B Sep/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025